An international comparison of the burden of illness in patients with dyspepsia

Digestive Diseases

Volumn 26, Issue 3, 2008, Pages 264-273

  Halling, Katarina ^a   Kulich, Károly ^a   Carlsson, Jonas ^a   Wiklund, Ingela ^a  

^a ASTRAZENECA R AND D   (Sweden)

Author keywords

Dyspepsia; Gastrointestinal Symptom Rating Scale; Health related quality of life; Multinational study; Patient reported outcomes; Quality of Life in Reflux and Dyspepsia questionnaire; Symptom severity

Indexed keywords

ABDOMINAL PAIN; ADULT; ANXIETY; ARTICLE; COMPARATIVE STUDY; CONSULTATION; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DYSPEPSIA; EMOTIONAL STRESS; FEMALE; GASTROINTESTINAL SYMPTOM RATING SCALE; GERMANY; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; HUNGARY; INDIGESTION; ITALY; MAJOR CLINICAL STUDY; MALE; POLAND; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUALITY OF LIFE; QUALITY OF LIFE IN REFLUX AND DYSPEPSIA QUESTIONNAIRE; QUESTIONNAIRE; SCORING SYSTEM; SHORT FORM 36; SLEEP; SOUTH AFRICA; SPAIN; SYMPTOM;

ADULT; AGE FACTORS; COST OF ILLNESS; CULTURAL CHARACTERISTICS; DYSPEPSIA; FEMALE; HEALTH SURVEYS; HUMANS; INTERNATIONAL COOPERATION; MALE; MIDDLE AGED; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRES; RISK ASSESSMENT; SEX FACTORS; SICKNESS IMPACT PROFILE; TIME FACTORS;

EID: 43449121548     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000128576     Document Type: Article

References (70)

1. Morrell DC, Gage HG, Robinson NA: Symptoms in general practice. J R Coll Gen Pract 1971;21:32-43.
2. McCormick A, Fleming DM, Charlton J: Morbidity statistics from general practice: fourth national study 1991-1992. London, Office of Population Censuses and Surveys, 1995. www.statistics.gov.uk/downloads/theme_health/MB5No3.pdf (accessed 28 February 2005).
3. Jones R, Lydeard S: Prevalence of symptoms of dyspepsia in the community. BMJ 1989;298:30-32.
4. Ahlawat SK, Richard Locke G, Weaver AL, Farmer SA, Yawn BP, Talley NJ: Dyspepsia consulters and patterns of management: a population-based study. Aliment Pharmacol Ther 2005;22:251-259.
5. Jones R, Liker H, Ducrotte P, Ballard K: Reasons why individuals with symptoms of gastroesophageal reflux disease seek medical attention. Gut 2005;54(suppl 7):A63.
6. Lydeard S, Jones R: Factors affecting the decision to consult with dyspepsia: comparison of consulters and non-consulters. J R Coll Gen Pract 1989;39:495-498.
7. Chiba N, Bernard L, O'Brien BJ, Goeree R, Hunt RH: A Canadian physician survey of dyspepsia management. Can J Gastroenterol 1998;12:83-90.
8. Dent J, Armstrong D, Delaney B, Moayyedi P, Talley NJ, Vakil N: Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs. Gut 2004;53(suppl 4):iv1-iv24.
9. McColl E: Best practice in symptom assessment: a review. Gut 2004;53(suppl 4):iv49-iv54.
10. McColl E, Junghard O, Wiklund I, Revicki D: Assessing symptoms in gastroesophageal reflux disease: how well do clinicians' assessments agree with those of their patients? Am J Gastroenterol 2005;100:11-18.
11. Moayyedi P, Delaney BC: Measuring gastroesophageal reflux symptoms: musings from Marrakech. Am J Gastroenterol 2005;100:19-20.
12. Food and Drug Administration: Patient-reported outcome measures: Use in medical product development to support labeling claims. Rockville, MD, US Department of Health and Human Services, 2006. www.fda.gov/cder/guidance/ 5460dft.htm (accessed 13 March 2006).
13. El-Serag HB, Talley NJ: Health-related quality of life in functional dyspepsia. Aliment Pharmacol Ther 2003;18:387-393.
14. Dent J: Definitions of reflux disease and its separation from dyspepsia. Gut 2002;50(suppl 4):iv17-iv20.
15. Talley NJ, Vakil N: Guidelines for the management of dyspepsia. Am J Gastroenterol 2005;100:2324-2337.
16. Madisch A, Kulich KR, Malfertheiner P, Ziegler K, Bayerdorffer E, Miehlke S, Labenz J, Carlsson J, Wiklund IK: Impact of reflux disease on general and disease-related quality of life - evidence from a recent comparative methodological study in Germany. Z Gastroenterol 2003;41:1137-1143.
17. Pique JM, Kulich KR, Vegazoc O, Jimenez J, Zapardiel J, Carlsson J, Wiklund I: Burden of gastroesophageal reflux disease. Evidence from a recent methodological study in Spain (in Spanish). Gastroenterol Hepatol 2004;27:300-306.
18. Ujszaszy L, Kulich RK, Toth GT, Barany L, Carlsson J, Wiklund I: Burden of illness in patients with reflux disease - evidence from a recent comparative methodological study in Hungary. Orv Hetil 2004;145(suppl 2):733-738.
19. Pacini F, Calabrese C, Cipolletta L, Valva MD, Russo A, Savarino V, Vigneri S: Burden of illness in Italian patients with gastro-oesophageal reflux disease. Curr Med Res Opin 2005;21:495-502.
20. Regula J, Kulich KR, Stasiewicz J, Jasinski B, Carlsson J, Wiklund I: Burden of illness in patients with reflux disease - evidence from a recent methodological study in Poland (in Polish). Przegl Epidemiol 2005;59:75-85.
21. van Rensburg CJ, Kulich KR, Carlsson J, Wiklund I: What is the burden of illness in patients with reflux disease in South Africa? S Afr Rev Gastroenterol 2005;3:16-21.
22. Dimenas E, Glise H, Hallerback B, Hernqvist H, Svedlund J, Wiklund I: Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand J Gastroenterol 1995;30:1046-1052.
23. Revicki DA, Wood M, Wiklund I, Crawley J: Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux disease. Qual Life Res 1998;7:75-83.
24. Talley NJ, Fullerton S, Junghard O, Wiklund I: Quality of life in patients with endoscopynegative heartburn: reliability and sensitivity of disease-specific instruments. Am J Gastroenterol 2001;96:1998-2004.
25. Jones R, Horbach S, Sander P, Ryden-Bergsten T: Heartburn in patients with gastro-oesophageal reflux disease in Germany and Sweden: a study on patients' burden of disease. Pharmacoeconomics 2003;21:1091-1102.
26. Dimenas E, Carlsson G, Glise H, Israelsson B, Wiklund I: Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease. Scand J Gastroenterol Suppl 1996;221:8-13.
27. Strid H, Simren M, Johansson AC, Svedlund J, Samuelsson O, Bjornsson ES: The prevalence of gastrointestinal symptoms in patients with chronic renal failure is increased and associated with impaired psychological general well-being. Nephrol Dial Transplant 2002;17:1434-1439.
28. Talley NJ, Meineche-Schmidt V, Pare P, Duckworth M, Raisanen P, Pap A, Kordecki H, Schmid V: Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies). Aliment Pharmacol Ther 1998;12:1055-1065.
29. Yeomans N, Wilson I, Langstrom G, Hawkey C, Naesdal J, Walan A, Wiklund I: Quality of life in chronic NSAID users: a comparison of the effect of omeprazole and misoprostol. Scand J Rheumatol 2001;30:328-334.
30. Galmiche JP, Barthelemy P, Hamelin B: Treating the symptoms of gastro-oesophageal reflux disease: a double-blind comparison of omeprazole and cisapride. Aliment Pharmacol Ther 1997;11:765-773.
31. Revicki DA, Sorensen S, Maton PN, Orlando RC: Health-related quality of life outcomes of omeprazole versus ranitidine in poorly responsive symptomatic gastroesophageal reflux disease. Dig Dis 1998;16:284-291.
32. Kaplan-Machlis B, Spiegler GE, Zodet MW, Revicki DA: Effectiveness and costs of omeprazole vs ranitidine for treatment of symptomatic gastroesophageal reflux disease in primary care clinics in West Virginia. Arch Fam Med 2000;9:624-630.
33. Mones J, Adan A, Segu JL, Lopez JS, Artes M, Guerrero T: Quality of life in functional dyspepsia. Dig Dis Sci 2002;47:20-26.
34. Suzuki H, Masaoka T, Sakai G, Ishii H, Hibi T: Improvement of gastrointestinal quality of life scores in cases of Helicobacter pyloripositive functional dyspepsia after successful eradication therapy. J Gastroenterol Hepatol 2005;20:1652-1660.
35. Wiklund IK, Junghard O, Grace E, Talley NJ, Kamm M, Veldhuyzen van Zanten S, Pare P, Chiba N, Leddin DS, Bigard MA, Colin R, Schoenfeld P: Quality of life in reflux and dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD). Eur J Surg Suppl 1998;583:41-49.
36. Svedlund J, Sjodin I, Dotevall G: GSRS - a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 1988;33:129-134.
37. Guillemin F, Bombardier C, Beaton D: Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol 1993;46:1417-1432.
38. Kulich KR, Malfertheiner P, Madisch A, Labenz J, Bayerdorffer E, Miehlke S, Carlsson J, Wiklund IK: Psychometric validation of the German translation of the Gastrointestinal Symptom Rating Scale (GSRS) and Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire in patients with reflux disease. Health Qual Life Outcomes 2003;1:62.
39. Kulich KR, Calabrese C, Pacini F, Vigneri S, Carlsson J, Wiklund IK: Psychometric validation of the Italian translation of the Gastrointestinal Symptom-Rating Scale and Quality of Life in Reflux and Dyspepsia Questionnaire in patients with gastro-oesophageal reflux disease. Clin Drug Invest 2004;24:205-215.
40. Kulich KR, Pique JM, Vegazo O, Jimenez J, Zapardiel J, Carlsson J, Wiklund I: Psychometric validation of translation to Spanish of the gastrointestinal symptoms rating scale (GSRS) and quality of life in reflux and dyspepsia (QOLRAD) in patients with gastroesophageal reflux disease (in Spanish). Rev Clin Esp 2005;205:588-594.
41. Kulich KR, Regula J, Stasiewicz J, Jasinski B, Carlsson J, Wiklund I: Psychometric validation of the Polish translation of the Gastrointestinal Symptom Rating Scale (GSRS) and Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire in patients with reflux disease (in Polish). Pol Arch Med Wewn 2005;113: 241-249.
42. van Rensburg CJ, Kulich KR, Carlsson J, Wiklund IK: Psychometric validation of the Afrikaans translation of two patient-reported outcomes instruments for reflux disease. S Afr Rev Gastroenterol 2006;4:5-9.
43. Ware JE: SF-36 Health Survey: Manual and Interpretation Guide. Boston, New England Medical Centre, 1993.
44. Ware JE, Gandek B, Kosinski M, Aaronson NK, Apolone G, Brazier J, Bullinger M, Kaasa S, Leplege A, Prieto L, Sullivan M, Thunedborg K: The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998;51:1167-1170.
45. Ware JE, Kosinski M, Gandek B, Aaronson NK, Apolone G, Bech P, Brazier J, Bullinger M, Kaasa S, Leplege A, Prieto L, Sullivan M: The factor structure of the SF-36 Health Survey in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998;51:1159-1165.
46. Gralnek IM, Hays RD, Kilbourne A, Naliboff B, Mayer EA: The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology 2000;119:654-660.
47. Kulig M, Leodolter A, Vieth M, Schulte E, Jaspersen D, Labenz J, Lind T, Meyer-Sabellek W, Malfertheiner P, Stolte M, Willich SN: Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease - an analysis based on the ProGERD initiative. Aliment Pharmacol Ther 2003;18:767-776.
48. Wiklund I, Talley NJ: Update on health-related quality of life in patients with gastroesophageal reflux disease. Expert Rev Pharmacoeconomics Outcomes Res 2003;3:341-350.
49. Wiklund I: Review of the quality of life and burden of illness in gastroesophageal reflux disease. Dig Dis 2004;22:108-114.
50. Faresjo A, Anastasiou F, Lionis C, Johansson S, Wallander MA, Faresjo T: Health-related quality of life of irritable bowel syndrome patients in different cultural settings. Health Qual Life Outcomes 2006;4:21.
51. Ware JE, Kosinski M, Gandek B: SF-36 Health Survey: Manual and Interpretation Guide. Lincoln, RI; Quality Metric Incorporated, 2000.
52. Zigmond AS, Snaith RP: The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-370.
53. Moorey S, Greer S, Watson M, Gorman C, Rowden L, Tunmore R, Robertson B, Bliss J: The factor structure and factor stability of the hospital anxiety and depression scale in patients with cancer. Br J Psychiatry 1991;158:255-259.
54. Herrmann C: International experiences with the Hospital Anxiety and Depression Scale - a review of validation data and clinical results. J Psychosom Res 1997;42:17-41.
55. World Medical Association: Declaration of Helsinki: ethical principles for medical research involving human subjects. Ferney-Voltaire, WMA, 2004. www.wma.net/e/policy/b3.htm (accessed 6 February 2006).
56. Wiklund I, Halling K, Flook N, Vakil N, Veldhuyzen van Zanten S, Lauritsen K, Persson T, Brun J, Svedberg L, Talley NJ: The burden of non-heartburn predominant dyspepsia on patients' lives. Results from the STARS II Study. Gastroenterology 2006;130(suppl 2):M1985.
57. Talley NJ, Locke GR III, Lahr BD, Zinsmeister AR, Tougas G, Ligozio G, Rojavin MA, Tack J: Functional dyspepsia, delayed gastric emptying, and impaired quality of life. Gut 2006;55:933-939.
58. Halder SL, Locke GR III, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ III: Impact of functional gastrointestinal disorders on health-related quality of life: a population-based case-control study. Aliment Pharmacol Ther 2004;19:233-242.
59. Stewart AL, Greenfield S, Hays RD, Wells K, Rogers WH, Berry SD, McGlynn EA, Ware JE Jr: Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study. JAMA 1989;262:907-913.
60. Wiklund I, Glise H, Jerndal P, Carlsson J, Talley NJ: Does endoscopy have a positive impact on quality of life in dyspepsia? Gastrointest Endosc 1998;47:449-454.
61. Meineche-Schmidt V, Talley NJ, Pap A, Kordecki H, Schmid V, Ohlsson L, Wahlqvist P, Wiklund I, Bolling-Sternevald E: Impact of functional dyspepsia on quality of life and health care consumption after cessation of antisecretory treatment. A multicentre 3-month follow-up study. Scand J Gastroenterol 1999;34:566-574.
62. Bodlund O: Anxiety and depression as a hidden problem in primary health care. Only one case in four identified (in Swedish). Läkartidningen 1997;94:4612-4614, 4617-4618.
63. Hall A, A'Hern R, Fallowfield L: Are we using appropriate self-report questionnaires for detecting anxiety and depression in women with early breast cancer? Eur J Cancer 1999;35:79-85.
64. Chiba N, Van Zanten SJ, Sinclair P, Ferguson RA, Escobedo S, Grace E: Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment-Helicobacter pylori positive (CADETHp) randomised controlled trial. BMJ 2002;324:1012-1016.
65. Manes G, Menchise A, de Nucci C, Balzano A: Empirical prescribing for dyspepsia: randomised controlled trial of test and treat versus omeprazole treatment. BMJ 2003;326:1118.
66. Moayyedi P, Soo S, Deeks J, Forman D, Mason J, Innes M, Delaney B: Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Dyspepsia Review Group. BMJ 2000;321:659-664.
67. Laine L, Schoenfeld P, Fennerty MB: Therapy for Helicobacter pylori in patients with nonulcer dyspepsia. A meta-analysis of randomized, controlled trials. Ann Intern Med 2001;134:361-369.
68. Talley N, Vakil N, Lauritsen K, Veldhuyzen van Zanten S, Flook N: An acid suppression trial with esomeprazole identifies patients with non-ulcer dyspepsia who will respond to prolonged acid suppression: a randomized controlled trial of 1589 endoscoped patients. Can J Gastroenterol 2005;19(suppl C):R.0066.
69. Veldhuyzen van Zanten S, Flook N, Talley N, Vakil N, Lauritsen K: An acid suppression trial with esomeprazole identifies patients with non-GERD dyspepsia who will respond to prolonged acid suppression: a randomized controlled trial of 1250 uninvestigated primary care patients. Can J Gastroenterol 2005;19(suppl C):R.0067.
70. Kulich K, Madisch A, Pacini F, Piqué J, Regula J, van Rensburg C, Újszászy L, Carlsson J, Halling K, Wiklund I: Reliability and validity of the Gastrointestinal Symptom Rating Scale (GSRS) and Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire in dyspepsia: A six-country study. Health Qual Life Outcomes 2008;6:12.